JNJ Insider Trading
Form 4 insider transactions for JNJ over the last 6 months. Buys, sells and grants by directors and officers.
| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Taubert Jennifer LEVP, WWC. Innovative Medicine | Aug 17, 2026 | Sell | 15,000 | $263.36 |
| Taubert Jennifer LEVP, WWC. Innovative Medicine | Aug 17, 2026 | Option exercise | 15,000 | $115.67 |
| Duato JoaquinCEO and Chairman of the Board | Aug 13, 2026 | Sell | 123,291 | $261.17 |
| Duato JoaquinCEO and Chairman of the Board | Aug 13, 2026 | Option exercise | 123,291 | $115.67 |
| Forminard ElizabethEVP, Chief Legal Officer | Aug 6, 2026 | Sell | 15,918 | $257.00 |
| Forminard ElizabethEVP, Chief Legal Officer | Aug 6, 2026 | Option exercise | 9,344 | $131.94 |
| Duato JoaquinCEO and Chairman of the Board | Aug 5, 2026 | Sell | 48,480 | $258.15 |
| Broadhurst VanessaEVP, Global Corp Affairs | Jul 20, 2026 | Sell | 23,054 | $251.27 |
| Broadhurst VanessaEVP, Global Corp Affairs | Jul 20, 2026 | Option exercise | 23,054 | $130.77 |
| Wengel Kathryn EEVP, Chief TO and Risk Officer | Jun 11, 2026 | Sell | 10,000 | $241.15 |
| Wengel Kathryn EEVP, Chief TO and Risk Officer | Jun 11, 2026 | Option exercise | 10,000 | $115.67 |
| REED JOHN CEVP, Innovative Medicine, R&D | May 1, 2026 | Tax withholding | 11,002 | $229.85 |
| REED JOHN CEVP, Innovative Medicine, R&D | May 1, 2026 | Option exercise | 25,255 | — |
Insider trading for companies related to JNJ
Never miss a JNJ filing.
Get an email when JNJ files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Source: SEC EDGAR Form 4 filings.